Figure 2.
Brachyury drives resistance to TNF-related apoptosis-inducing ligand (TRAIL) in cells expressing a wild-type p53 gene. (A) Western blot analysis of brachyury, vimentin, E-cadherin, and p21 in H460 clones generated via the CRISPR/Cas9 system. (B,C) Western blot analysis of brachyury expression in HCT116 and H1229 cells, respectively, stably transfected with either a control or brachyury-encoding (pBr) plasmid. (D) The impact of brachyury expression on the sensitivity of HCT116 (left panel) and H1229 (right panel) to lysis by a range of TRAIL doses.
